Hosted on MSN7mon
Emcure Pharmaceuticals IPO listing tomorrow: Here’s what GMP, subscription status indicate ahead of listingGMP and other details Emcure Pharmaceuticals, a Pune-based business, conducts research, develops, produces, and markets pharmaceutical products worldwide across many therapeutic areas. The shares ...
Emcure Pharmaceuticals posted a 35.4 per cent year-on-year (Y-o-Y) growth in its consolidated net profit at Rs 153.7 crore ...
Emcure Pharmaceuticals on Thursday reported a 30.3% year-on-year (YoY) increase in net profit to Rs.156 crore in Q3FY25 led ...
Emcure Pharmaceuticals on Thursday said it has launched a product range aimed at supporting women through their menopausal journey. The Arth range of products addresses the challenges faced by ...
Hosted on MSN7mon
Emcure Pharma to make stock market debut on Wednesday; here's what to expect as GMP correctsShares of Emcure Pharmaceuticals are to make their Dalal Street debut on Wednesday, July 10 and the drugmaker is expected to deliver a decent listing pop to the investors, even after its grey ...
Emcure Pharma on February 6 reported a net profit of Rs 153.72 crore for the third quarter of the current financial year. This marks a rise of over 35 percent from the Rs 113.45 crore net profit ...
Emcure Pharma inaugurates world-class R&D centre in Ahmedabad: Our Bureau, Mumbai Thursday, January 23, 2025, 16:30 Hrs [IST] Emcure Pharmaceuticals Limited, one of India’s lead ...
Emcure Pharmaceutica - Announcement under ... is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre in Ahmedabad, in the Indian state of Gujarat. The centre will focus on developing complex drug delivery ...
Pune-based Emcure Pharmaceuticals Ltd inaugurated its “biggest” Formulation ... then we have to give products which are different. That’s the job which my R&D has done.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results